PRELUDE CAPITAL MANAGEMENT, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 175 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$959,000
+4.2%
8,950
-0.0%
0.02%
+4.2%
Q3 2021$920,000
+31.6%
8,951
+12.6%
0.02%
+14.3%
Q2 2021$699,000
+421.6%
7,950
+448.3%
0.02%
+250.0%
Q3 2020$134,000
-79.4%
1,450
-82.1%
0.01%
-76.0%
Q4 2019$649,000
+1375.0%
8,100
+1250.0%
0.02%
+1150.0%
Q3 2019$44,000
-93.9%
600
-93.5%
0.00%
-95.2%
Q3 2018$716,000
+215.4%
9,172
+156.3%
0.04%
+200.0%
Q2 2018$227,000
+404.4%
3,579
+496.5%
0.01%
+250.0%
Q4 2017$45,000
+275.0%
600
+155.3%
0.00%
+300.0%
Q2 2017$12,0002350.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders